ImmunoPrecise Antibodies Ltd. financial data

Symbol
IPA on Nasdaq
Location
3204 4464 Markham St., Victoria, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
April 30
Latest financial report
6-K - Q4 2023 - Mar 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.1M shares +2.34%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1M CAD -36%
General and Administrative Expense 4.18M CAD +1.61%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 18.7M CAD
Assets 78.7M CAD
Liabilities 28.9M CAD